You are here


LONDON, April 17 (Reuters) - Scientists and drugmakers are pioneering a new kind of clinical trial that changes the way cancer drugs are studied, potentially cutting both the time and cost of... Read more
Building on enthusiasm for the multi-sponsor, multi-drug clinical trial due to get underway in lung cancer soon, stakeholders in academia, industry, government and the patient community have begun... Read more
Draft guidance calls for a clear statement in the Indications and Usage section of labeling that reflects a drug’s clearance under accelerated approval on the basis of a particular surrogate or... Read more
The vast majority of patients believe that pharmaceutical companies should provide services that complement the products they provide, whether they are taking long-term, short-term or lifestyle... Read more
With the excitement about FDA’s breakthrough designation continuing to grow, patients now are looking to gain some influence over the process, although it is unclear how the agency would incorporate... Read more
In 16 years, cancer will become the leading cause of death in the United States, surpassing heart disease, according to a new report from the American Society of Clinical Oncology. The number of new... Read more
Some of the more exciting ideas in biotech are coming up in molecular diagnostics. There’s cool science at work. A number of tests have potential to cut down on overtreatment, reduce waste in... Read more
In the summer of 2012, a year after his wife had died of lung cancer, Michael Harris scraped open an old mole on his back and it would not stop bleeding. The doctors said he had stage 4 melanoma,... Read more
Washington, DC – Friends of Cancer Research (Friends), a Washington, DC-based think tank and advocacy organization, announced the appointment of Joel S. Marcus, Chairman, Chief Executive Officer, and... Read more
Last year’s 39 NME approvals is not the “new normal,” Office of New Drugs Director John Jenkins declares. FDA approved just 27 NMEs in 2013. The return to normal also included a quiet December.For... Read more